DK0635495T3 - Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem - Google Patents
Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende demInfo
- Publication number
- DK0635495T3 DK0635495T3 DK94401547T DK94401547T DK0635495T3 DK 0635495 T3 DK0635495 T3 DK 0635495T3 DK 94401547 T DK94401547 T DK 94401547T DK 94401547 T DK94401547 T DK 94401547T DK 0635495 T3 DK0635495 T3 DK 0635495T3
- Authority
- DK
- Denmark
- Prior art keywords
- branched
- linear
- group
- unsubstituted
- substituted
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9308859A FR2707981B1 (fr) | 1993-07-20 | 1993-07-20 | Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0635495T3 true DK0635495T3 (da) | 1999-06-14 |
Family
ID=9449385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94401547T DK0635495T3 (da) | 1993-07-20 | 1994-07-06 | Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5486532A (da) |
| EP (1) | EP0635495B1 (da) |
| JP (1) | JP3103271B2 (da) |
| AT (1) | ATE171166T1 (da) |
| AU (1) | AU673438B2 (da) |
| CA (1) | CA2128119C (da) |
| DE (1) | DE69413333T2 (da) |
| DK (1) | DK0635495T3 (da) |
| ES (1) | ES2124379T3 (da) |
| FR (1) | FR2707981B1 (da) |
| NZ (1) | NZ264037A (da) |
| ZA (1) | ZA945336B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04174725A (ja) * | 1990-10-30 | 1992-06-22 | Kanebo Ltd | 紡績装置におけるドラフト装置 |
| FR2787450B1 (fr) * | 1998-12-18 | 2001-01-26 | Adir | Nouveaux derives spiroimidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP2323734A1 (en) * | 2008-08-04 | 2011-05-25 | Schering Corporation | Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| AR073630A1 (es) * | 2008-10-07 | 2010-11-17 | Schering Corp | Analogos de espiroaminooxazolina como moduladores de los receptores adrenergicos alfa2c |
| US8324213B2 (en) | 2008-10-07 | 2012-12-04 | Merck Sharp & Dohme Corp. | Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators |
| EP2482661A4 (en) * | 2009-10-01 | 2013-03-06 | Merck Sharp & Dohme | REVERSED BIARYL SPIROAMINOOXAZOLINE ANALOGS AS ALPHA-2C ADRENERGE RECEPTOR MODULATORS |
| CN110393714B (zh) * | 2019-08-02 | 2022-09-02 | 上海市肿瘤研究所 | 一种抗肿瘤药物、合成方法及应用 |
| CN116120232B (zh) * | 2023-02-24 | 2024-09-03 | 上海市肿瘤研究所 | 一种dna-螺烯纳米药物及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3429892A (en) * | 1967-03-14 | 1969-02-25 | Smithkline Corp | Spiro(naphthalene-2,2'-oxazolidine) compounds |
| US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
| US4226875A (en) * | 1979-04-02 | 1980-10-07 | Pfizer Inc. | Novel spiro-oxazolidinediones |
| ZA832679B (en) * | 1982-05-07 | 1983-12-28 | Ici Plc | Indoline derivatives |
| FR2709306B1 (fr) * | 1993-07-20 | 1995-10-20 | Adir | Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| FR2707982B1 (fr) * | 1993-07-20 | 1995-09-01 | Adir | Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1993
- 1993-07-20 FR FR9308859A patent/FR2707981B1/fr not_active Expired - Fee Related
-
1994
- 1994-07-06 DE DE69413333T patent/DE69413333T2/de not_active Expired - Fee Related
- 1994-07-06 DK DK94401547T patent/DK0635495T3/da active
- 1994-07-06 ES ES94401547T patent/ES2124379T3/es not_active Expired - Lifetime
- 1994-07-06 EP EP94401547A patent/EP0635495B1/fr not_active Expired - Lifetime
- 1994-07-06 AT AT94401547T patent/ATE171166T1/de not_active IP Right Cessation
- 1994-07-15 CA CA002128119A patent/CA2128119C/fr not_active Expired - Fee Related
- 1994-07-18 AU AU67548/94A patent/AU673438B2/en not_active Ceased
- 1994-07-19 US US08/276,910 patent/US5486532A/en not_active Expired - Fee Related
- 1994-07-19 NZ NZ264037A patent/NZ264037A/en unknown
- 1994-07-20 JP JP06168029A patent/JP3103271B2/ja not_active Expired - Fee Related
- 1994-07-20 ZA ZA945336A patent/ZA945336B/xx unknown
-
1995
- 1995-04-11 US US08/420,064 patent/US5648374A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0635495A2 (fr) | 1995-01-25 |
| EP0635495B1 (fr) | 1998-09-16 |
| JPH07165728A (ja) | 1995-06-27 |
| AU6754894A (en) | 1995-02-02 |
| ATE171166T1 (de) | 1998-10-15 |
| US5486532A (en) | 1996-01-23 |
| FR2707981B1 (fr) | 1995-09-01 |
| CA2128119C (fr) | 2002-02-26 |
| NZ264037A (en) | 1995-04-27 |
| DE69413333D1 (de) | 1998-10-22 |
| ES2124379T3 (es) | 1999-02-01 |
| FR2707981A1 (fr) | 1995-01-27 |
| JP3103271B2 (ja) | 2000-10-30 |
| US5648374A (en) | 1997-07-15 |
| ZA945336B (en) | 1995-02-28 |
| EP0635495A3 (fr) | 1995-02-22 |
| CA2128119A1 (fr) | 1995-01-21 |
| DE69413333T2 (de) | 1999-05-12 |
| AU673438B2 (en) | 1996-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2109672T3 (es) | 1,4-tiazepinas condensadas hipolipidemicas. | |
| DK0457686T3 (da) | Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| AU663200B2 (en) | New 3-(hydroxybenzylidenyl)-indolin-2-ones, processes for their preparation and pharmaceutical compositions containing them | |
| DK0635497T3 (da) | Benzospiroalkenderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse | |
| DK0635495T3 (da) | Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem | |
| ES8304076A1 (es) | "procedimiento de preparacion de compuestos del tipo arilbencensulfonamida". | |
| DK0452204T3 (da) | Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK0635496T3 (da) | Benzospiroalkenderivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende sådanne | |
| MY109729A (en) | Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same | |
| FI954213A0 (fi) | Kasvainten vastaisia koostumuksia ja hoitomenetelmiä | |
| FI903511A0 (fi) | Pyrrolo (2,1-b) tiazolderivat. | |
| DK0412015T3 (da) | Hidtil ukendte N-(23-vincristinoyl)- og N-(5-noranhydro-23-vinblastinoyl)-1-aminomethylphosphon- syrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| AU659738B2 (en) | New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| DK0518753T3 (da) | Hidtil ukendte 1,5-diyn-3-cykloalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| PL304334A1 (en) | Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract | |
| ZA939576B (en) | P-(bis(2-chloroethyl) amino)phenylalanine compounds process for preparing them and pharmaceutical compositions containing them |